Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
TMOm | Buenos Aires | ARS | Delayed | |
TMO | NYSE | USD | Real-time | |
TMO | CBOE Canada | CAD | Real-time | |
TMO | Mexico | MXN | Delayed | |
1TMO | Milan | EUR | Real-time | |
TMO | TradeGate | EUR | Delayed | |
TMOS34 | B3 | BRL | Delayed | |
TMO | Vienna | EUR | Real-time | |
TMO | Lima | USD | Delayed |
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company’s Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
Name | Age | Since | Title |
---|---|---|---|
Marc N. Casper | 54 | 2001 | Chairman, President & CEO |
Scott M. Sperling | 65 | 2006 | Independent Lead Director |
R. Alexandra Keith | 55 | 2020 | Independent Director |
Thomas Conrads | - | - | Member of Scientific Advisory Board |
Jonathan S. Weissman | - | 2022 | Member of Scientific Advisory Board |
Mark P. Stevenson | 60 | 2014 | Member of Scientific Advisory Board |
Karen Akinsanya | 55 | - | Member of Scientific Advisory Board |
Nelson Juseuk Chai | 57 | 2010 | Independent Director |
James C. Mullen | 64 | 2018 | Independent Director |
Dion J. Weisler | 56 | 2017 | Independent Director |
Cynthia Wolberger | - | 2017 | Member of Scientific Advisory Board |
Laura Sepp-Lorenzino | 62 | 2018 | Member of Scientific Advisory Board |
Debora L. Spar | 59 | 2019 | Independent Director |
Kristala Lanett Jones Prather | - | - | Member of Scientific Advisory Board |
Ruby R. Chandy | 61 | 2022 | Independent Director |
Tyler E. Jacks | 63 | 2009 | Member of Scientific Advisory Board & Director |
Jennifer M. Johnson | 60 | 2023 | Independent Director |
Lars Rebien Sorensen | 70 | 2016 | Independent Director |
William C. Hahn | - | - | Member of Scientific Advisory Board |
C. Martin Harris | 68 | 2012 | Independent Director & Member of Scientific Advisory Board |
Steven P. Gygi | - | - | Member of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review